Kenan Izgi1,3, Banu Iskender2,3, Cagri Sakalar2,3, Aslihan Arslanhan1,3, Berkay Saraymen1,4, Halit Canatan2,3
European Cytokine Network, Vol.26, No.2, pp. 46-56, 2015, DOI:10.1684/ecn.2015.0365
Abstract Rationale: Organ- or tissue-specific antigens produced by normal tissue or by cancer cells could be
used in cancer immunotherapy, to target the tumor. In our previous study, we induced T-cell-mediated, bladder-specific
autoimmunity by targeting the bladder-specific protein Uroplakin 3A (UPK3A). UPK3A is a well-chosen
target for developing an autoimmune response against bladder cancer since the antigen is also expressed in bladder
tumors. To use this peptide, which was derived from the UPK3A protein in a bladder cancer vaccine study, it is
necessary to induce a strong immune response. In this study, we aimed to develop… More >